Corrigendum to "COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis" [Brain Behav. Immun. 111 (2023) 211-229].

Ceban, Felicia; Kulzhabayeva, Dana; Rodrigues, Nelson B; Di Vincenzo, Joshua D; Gill, Hartej; Subramaniapillai, Mehala; Lui, Leanna M W; Cao, Bing; Mansur, Rodrigo B; Ho, Roger C; Burke, Matthew J; Rhee, Taeho Greg; Rosenblat, Joshua D; McIntyre, Roger S

Ceban, Felicia; Kulzhabayeva, Dana; Rodrigues, Nelson B; Di Vincenzo, Joshua D; Gill, Hartej; Subramaniapillai, Mehala; Lui, Leanna M W; Cao, Bing; Mansur, Rodrigo B; Ho, Roger C; Burke, Matthew J; Rhee, Taeho Greg; Rosenblat, Joshua D; McIntyre, Roger S.

Afiliação

Ceban F; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada.
Kulzhabayeva D; Department of Psychology, University of Toronto, Toronto, Ontario, Canada.
Rodrigues NB; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.
Di Vincenzo JD; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.
Gill H; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Subramaniapillai M; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada.
Lui LMW; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Cao B; Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, China.
Mansur RB; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Ho RC; Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore; Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore 119077, Singapore.
Burke MJ; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Canada; Department of Neurology, Division of Cognitive Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Rhee TG; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA; Department of Public Health Sciences, University of Connecticut School of Medicine, Farmington, CT, USA.
Rosenblat JD; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
McIntyre RS; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto

Brain Behav Immun ; 115: 758, 2024 Jan.

Article em En | MEDLINE | ID: mdl-37806865

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Brain Behav Immun Assunto da revista: ALERGIA E IMUNOLOGIA / CEREBRO / PSICOFISIOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google